Fibroblast Growth Factor 23: Potential Marker of Invisible Heart Damage in Diabetic Population

Fibroblast Growth Factor 23: Potential Marker of Invisible Heart Damage in Diabetic Population

Two-dimensional speckle-tracking echocardiography (2DSTE) detects myocardial dysfunction despite a preserved left ventricular ejection fraction. Fibroblast growth factor 23 (FGF23) has become a promising biomarker of cardiovascular risk. This study aimed to determine whether FGF23 may be used as a m...

Full description

Bibliographic Details
Main Authors: Anna Kurpas, Karolina Supel, Paulina Wieczorkiewicz, Joanna Bodalska Duleba, Marzenna Zielinska
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Biomedicines
Subjects:
fibroblast growth factor 23
two-dimensional speckle-tracking echocardiography
left ventricular diastolic dysfunction
diabetes mellitus
Online Access:https://www.mdpi.com/2227-9059/11/6/1523

Internet

https://www.mdpi.com/2227-9059/11/6/1523

Similar Items